Literature DB >> 7870738

Lipids and cardiac arrhythmia.

J S Charnock1.   

Abstract

In any discussion of lipids and heart disease it is beneficial from the outset to recognise that at least three different pathological processes may be involved. The first of these is atherosclerosis which involves the deposition of "fat" in the coronary vessels, another is thrombogenesis which describes the formation of blood clots in the coronary vessels, and the third is arrhythmia which refers to disorders in the beating of the heart which may become sufficiently serious to cause sudden cardiac death (SCD). Also it is this disturbance in the rhythmic beating of the heart which is responsible for much of the mortality from 'heart attacks' which occur 'outside-of-hospital' in societies like U.S.A., U.K. and Australia. It is this latter condition of cardiac arrhythmia which is the major concern of this review. Because it is often difficult to differentiate the role of lipids in 'heart disease' in man, it has frequently been assumed that all dietary fatty acids have similar effects on the different processes involved, and many unwarranted generalisations have been made which have led to conflicts of opinion amongst physicians and confusion in the lay public. From the animal studies discussed in this review, it is apparent that dietary fatty acids have an important role to play in determining the vulnerability of the myocardium to develop serious ventricular fibrillation (VF) and potentially lethal cardiac arrhythmia. In general, diets rich in saturated fatty acids promote a state of myocardial vulnerability, whilst diets rich in PUFA significantly diminish the probability of developing lethal disorders in cardiac rhythm when the heart is placed under pharmacological (or emotional) stress, or deprived of sufficient blood flow and supply of oxygen. Very recent experiments with the monounsaturated fatty acid (MUFA) oleic acid clearly demonstrate that, at least in rats subjected to ligation of their coronary artery, this acid is not 'neutral' as has been suggested by some for its role in atherosclerosis, but in fact is indistinguishable from saturated fatty acids in its effect in promoting arrhythmia during either regional ischaemia or reperfusion arrhythmia in this animal model of SCD.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7870738     DOI: 10.1016/0163-7827(94)90023-x

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  13 in total

1.  Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991.

Authors:  W A Zatonski; A J McMichael; J W Powles
Journal:  BMJ       Date:  1998-04-04

2.  Suppression of inositol phosphate release by cardiac myocytes isolated from fish oil-fed pigs.

Authors:  S S Nair; J Leitch; M L Garg
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

Review 3.  PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty.

Authors:  Janice V Huang; Clifford R Greyson; Gregory G Schwartz
Journal:  J Lipid Res       Date:  2012-06-08       Impact factor: 5.922

Review 4.  Membrane basis for fish oil effects on the heart: linking natural hibernators to prevention of human sudden cardiac death.

Authors:  P L McLennan; M Y Abeywardena
Journal:  J Membr Biol       Date:  2005-07       Impact factor: 1.843

5.  Specific modifications of phosphatidylinositol and nonesterified fatty acid fractions in cultured porcine cardiomyocytes supplemented with n-3 polyunsaturated fatty acids.

Authors:  S S Nair; J Leitch; M L Garg
Journal:  Lipids       Date:  1999-07       Impact factor: 1.880

6.  Regulation of beta-adrenoceptor properties and the lipid milieu in heart muscle membranes during stress.

Authors:  S Gudbjarnason; V E Benediktsdóttir
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

Review 7.  Lipid metabolites and their differential pro-arrhythmic profiles: of importance in the development of a new anti-arrhythmic pharmacology.

Authors:  Yangzhen Shao; Bjorn Redfors; David Benoist; Sigfus Gizurarson; Elmir Omerovic
Journal:  Mol Cell Biochem       Date:  2014-04-27       Impact factor: 3.396

8.  Dietary lipid modification of myocardial eicosanoids following ischemia and reperfusion in the rat.

Authors:  M Y Abeywardena; J S Charnock
Journal:  Lipids       Date:  1995-12       Impact factor: 1.880

9.  Long-chain n-3 polyunsaturated fatty acid incorporation into human atrium following fish oil supplementation.

Authors:  Manohar L Garg; James Leitch; Robert J Blake; Rahul Garg
Journal:  Lipids       Date:  2006-12       Impact factor: 1.646

10.  TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT.

Authors:  Harsha D Devalla; Roselle Gélinas; Elhadi H Aburawi; Abdelaziz Beqqali; Philippe Goyette; Christian Freund; Marie-A Chaix; Rafik Tadros; Hui Jiang; Antony Le Béchec; Jantine J Monshouwer-Kloots; Tom Zwetsloot; Georgios Kosmidis; Frédéric Latour; Azadeh Alikashani; Maaike Hoekstra; Jurg Schlaepfer; Christine L Mummery; Brian Stevenson; Zoltan Kutalik; Antoine Af de Vries; Léna Rivard; Arthur Am Wilde; Mario Talajic; Arie O Verkerk; Lihadh Al-Gazali; John D Rioux; Zahurul A Bhuiyan; Robert Passier
Journal:  EMBO Mol Med       Date:  2016-12-01       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.